Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Narcotrend Depth of Anaesthesia Monitor as an Indicator of Seizures and Burst Suppression in the Intensive Care Unit

NCT06067750 is registered in ClinicalTrials.gov with Nottingham University Hospitals NHS Trust as lead sponsor.

NCT NCT06067750
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06067750 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Narcotrend Depth of Anaesthesia Monitor as an Indicator of Seizures and Burst Suppression in the Intensive Care Unit
Lead sponsor
Nottingham University Hospitals NHS Trust
Phase
Observational
Overall status
Completed
Start date
June 27, 2023
Completion date
May 25, 2024
Enrollment
44 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute ischemic stroke, encephalitis, icp (intracranial pressure) increase, intracerebral haemorrhage, seizures, status epilepticus, subarachnoid hemorrhage, subdural hematoma, traumatic brain injury